VIC Market Research

CATEGORY

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Outlook 2025-2031

Single：$3300USD Multi：$4300USD Enterprise：$5300USD

2025-04-19 11:48:58

Pages: 112

Tables: 130

Description
Table Of Contents
Tables And Figures
Research Methodology

OVERVIEW

Vic Market Research Co., Ltd. is pleased to announce the release of the “Global and Chinese Chemotherapy Induced Peripheral Neuropathy Treatment Market Insight Report 2025–2031.”
This comprehensive study is designed to provide a structured and in-depth analysis of the Chemotherapy Induced Peripheral Neuropathy Treatment industry, both domestically and internationally, with a focus on the following key areas:

1.An overview and assessment of the current development status and emerging trends in the Chemotherapy Induced Peripheral Neuropathy Treatment industry across global and Chinese markets.
2.Estimation of the overall market size of the Chemotherapy Induced Peripheral Neuropathy Treatment industry, along with a detailed analysis of market share by major countries.
3.Evaluation of the development potential within various segments of the Chemotherapy Induced Peripheral Neuropathy Treatment industry, analysis of downstream market demand, and an examination of the competitive landscape.
4.Identification and exploration of industry pain points, aiming to support stakeholders in addressing key challenges effectively.

This report integrates extensive desk research with qualitative interviews conducted with industry experts and insiders, ensuring both the objectivity and comprehensiveness of the findings and data.

The study provides a detailed examination of the production, consumption, import, and export dynamics of the Chemotherapy Induced Peripheral Neuropathy Treatment market in China. It also highlights key global and domestic manufacturers that play a significant role in the Chinese market, presenting core performance indicators such as sales volume, revenue, pricing, gross margin, and market share.

Furthermore, the report delivers a thorough analysis of segmented growth within the Chemotherapy Induced Peripheral Neuropathy Treatment product category, including differentiation by product types, pricing, sales, revenue, and application-specific market performance. Historical data from 2020 to 2024 is incorporated, with forward-looking projections extending through 2031.

In light of the significant uncertainty introduced by the U.S. tariff policy set to take effect in 2025, the report offers a dedicated analysis of its core impacts. This includes assessments of global and regional competitive dynamics, economic linkages, supply chain restructuring, and countries’ strategic responses. The report concludes with strategic recommendations and a forward-looking outlook for the Chemotherapy Induced Peripheral Neuropathy Treatment market.

1. Key Global Players in the Chemotherapy Induced Peripheral Neuropathy Treatment Industry:
Aptinyx Inc
Asahi Kasei Pharma Corp
Regenacy Pharmaceuticals
MAKScientific LLC
Metys Pharmaceuticals AG
Nemus Bioscience Inc
PledPharma
Sova Pharmaceuticals Inc
DermaXon LLC
Kineta Inc
Krenitsky Pharmaceuticals Inc
PeriphaGen
Apexian Pharma
WinSanTor

2.Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmented by Product Type:
Calcium Channel α2-delta Ligands
Antidepressants
Opioids
Others

3. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmented by Application
Platinum Agents
Taxanes
Vinca Alkaloids
Others

4. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, by Geographical Region:
North America (USA and Canada)
Europe (Germany, UK, France, Italy and other European countries)
Asia-Pacific (China, Japan, Korea, Taiwan, Southeast Asia, India, etc.)
Latin America (Mexico and Brazil, etc.)
Middle East and Africa (Turkey and Saudi Arabia, etc.)

I. Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview:

1.1 Product Definition and Statistical Scope

1.2 On the basis of different product types, Chemotherapy Induced Peripheral Neuropathy Treatment can be mainly categorized as follows:
Global Growth Trend of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type 2020 VS 2024 VS 2031
Calcium Channel α2-delta Ligands
Antidepressants
Opioids
Others

1.3 From different applications, Chemotherapy Induced Peripheral Neuropathy Treatment mainly includes the following:
Global Different Applications Chemotherapy Induced Peripheral Neuropathy Treatment Growth Trend 2020 VS 2024 VS 2031
Platinum Agents
Taxanes
Vinca Alkaloids
Others

1.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Development Status and Future Trends (2020-2031)
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Growth Rate (2020-2031)
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Growth Rate (2020-2031)

II. Global Market Major Chemotherapy Induced Peripheral Neuropathy Treatment Manufacturers Analysis:

2.1 Global Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Market Share
Global Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Sales (2020-2025)
Global Market Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share (2020-2025)

2.2 Global Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Market Share
Global Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Revenue (2020-2025)
Global Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share (2020-2025)
Global Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Ranking by 2024

2.3 Global Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Price (2020-2025)

2.4 Global Market Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Headquarter and Origin Distribution

2.5 Global Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Establishment Date and Chemotherapy Induced Peripheral Neuropathy Treatment Commercialization Date

2.6 Global Market Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Product Type and Application

2.7 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Concentration, Competition Analysis
Chemotherapy Induced Peripheral Neuropathy Treatment Industry Concentration Analysis: Global Top 5 Manufacturers Market Share by 2024
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment First Tier, Second Tier and Third Tier Manufacturers (Brand) and Market Share in 2024.

2.8 New Investments and Market M&A Activities

III. Profiles of the following key players:
Aptinyx Inc
Asahi Kasei Pharma Corp
Regenacy Pharmaceuticals
MAKScientific LLC
Metys Pharmaceuticals AG
Nemus Bioscience Inc
PledPharma
Sova Pharmaceuticals Inc
DermaXon LLC
Kineta Inc
Krenitsky Pharmaceuticals Inc
PeriphaGen
Apexian Pharma
WinSanTor

1. Basic Information, Chemotherapy Induced Peripheral Neuropathy Treatment Manufacturing Base, Headquarters, Competitors and Market Position.
2. Chemotherapy Induced Peripheral Neuropathy Treatment Product Specifications, Parameters, and Market Applications .
3. Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price and Gross Margin in Global Market (2020-2025).
4. Company Profile and Key Businesses.
5. Latest Company News.

IV. Analysis of Different Product Types of Chemotherapy Induced Peripheral Neuropathy Treatment:

4.1 Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Product Type (2020-2031)
Global Market Sales and Market Share of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type (2020-2025)
Global Market Sales Forecast of Chemotherapy Induced Peripheral Neuropathy Treatment by Different Product Types (2026-2031)

4.2 Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Size by Product Type (2020-2031)
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Size and Market Share by Product Type (2020-2025)
Global Market Size Forecast of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type (2026-2031)

4.3 Global Market Price Trend of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type (2020-2031)

V. Analysis of Chemotherapy Induced Peripheral Neuropathy Treatment for Different Applications

5.1 Global Market Sales of Chemotherapy Induced Peripheral Neuropathy Treatment by Application (2020-2031)
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Market Share by Application (2020-2025)
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Sales Forecast by Application (2026-2031)

5.2 Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Size and Market Share by Application (2020-2025)
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Size Forecast by Application (2026-2031)

5.3 Global Market Price Trend of Chemotherapy Induced Peripheral Neuropathy Treatment by Application (2020-2031)

VI. Industry Development Environment Analysis

6.1 Development Analysis of Chemotherapy Induced Peripheral Neuropathy Treatment Industry - Development Trend

6.2 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Development Analysis - Manufacturer Barriers

6.3 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Development Analysis - Driving Factors

6.4 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Development Analysis - Restraints

6.5 SWOT Analysis of Chemotherapy Induced Peripheral Neuropathy Treatment Global Companies

6.6 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Development Analysis - Industry Policies
Industry Authorities and Regulatory Framework
Industry-related Policy Trends
Industry Related Planning

VII. Industry Supply Chain Analysis

7.1 Industry Chain Introduction of Chemotherapy Induced Peripheral Neuropathy Treatment Industry
7.2 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Chain Analysis - Upstream
7.3 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Chain Analysis - Midstream
7.4 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Chain Analysis - Downstream
7.5 Procurement Mode of Chemotherapy Induced Peripheral Neuropathy Treatment Industry
7.6 Production Mode of Chemotherapy Induced Peripheral Neuropathy Treatment Industry
7.7 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Sales Model and Sales Channels

VIII. Global Local Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production Analysis

8.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Supply and Demand Status and Forecast (2020-2031)
Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Capacity Utilization and Development Trend (2020-2031)
Global Chemotherapy Induced Peripheral Neuropathy Treatment Production, Market Demand and Development Trend (2020-2031)

8.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Import and Export Analysis
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Main Import Sources
Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Main Export Destinations

IX. Research Findings and Conclusion

X. Appendix

10.1 Research Methodology

10.2 Data Sources
Secondary Information Sources
Primary Information Sources

10.3 Data Interactive Validation

10.4 Disclaimer”

Table of Contents
Table : Growth Trends in Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table:Growth Trend of Different Applications
Table:Current Development Status of Chemotherapy Induced Peripheral Neuropathy Treatment Industry
Table:Development Trend of Chemotherapy Induced Peripheral Neuropathy Treatment
Table:Global Major Regions Production of Chemotherapy Induced Peripheral Neuropathy Treatment
Table:Global Major Regions Chemotherapy Induced Peripheral Neuropathy Treatment Production Market Share
Table:Global Market Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Production Capacity
Table:Global Market Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Sales Market Share, Sales Revenue
Table:Global Market Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Market Share, Price
Table: Global Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Ranking by 2025
Table: China Market Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Sales Market Share, Sales Revenue
Table: China Market Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Market Share, Sales Price
Table: China Key Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Ranking by 2025
Table: Global Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Production Distribution and Commercialization Date
Table:Global Major Manufacturers Chemotherapy Induced Peripheral Neuropathy Treatment Product Type List
Table: Global Key Manufacturers Market Position of Chemotherapy Induced Peripheral Neuropathy Treatment in 2025 (First Tier, Second Tier and Third Tier)
Table: Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis of Current Status of Investments, Mergers & Acquisitions, and Others
Table: Global Major Regions Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue
Table: Global Major Regions Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Market Share
Table: Global Major Regions Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share
Table: Global Major Regions Chemotherapy Induced Peripheral Neuropathy Treatment Sales Volume
Table: Global Major Regions Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share
Table : Global Major Regions Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share
Table : The following companies:
Aptinyx Inc
Asahi Kasei Pharma Corp
Regenacy Pharmaceuticals
MAKScientific LLC
Metys Pharmaceuticals AG
Nemus Bioscience Inc
PledPharma
Sova Pharmaceuticals Inc
DermaXon LLC
Kineta Inc
Krenitsky Pharmaceuticals Inc
PeriphaGen
Apexian Pharma
WinSanTor

Chemotherapy Induced Peripheral Neuropathy Treatment Manufacturing Base, Sales Area, Competitors and Market Position
Chemotherapy Induced Peripheral Neuropathy Treatment Product Specifications, Parameters and Market Applications
Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Revenue, Price and Gross Margin
Company Profile and Major Businesses
Latest Company News

Table: Global Sales of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table: Global Sales Market Share of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table: Global Sales Forecast of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table: Global Sales Market Share Forecast of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table: Global Revenue of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table: Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share by Product Type
Table: Global Revenue Forecast of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table: Global Revenue Market Share Forecast of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table: Global Price Trend of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Table: Global Sales of Chemotherapy Induced Peripheral Neuropathy Treatment by Application
Table: Global Sales Market Share of Chemotherapy Induced Peripheral Neuropathy Treatment by Application
Table: Global Sales Forecast of Chemotherapy Induced Peripheral Neuropathy Treatment by Application
Table: Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share Forecast by Application
Table: Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue by Application
Table: Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share by Application
Table: Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Forecast by Application
Table: Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share Forecast by Application
Table: Global Price Trend of Chemotherapy Induced Peripheral Neuropathy Treatment by Application
Table: List of Chemotherapy Induced Peripheral Neuropathy Treatment Upstream Raw Material Suppliers and Contact Information
Table: List of Typical Customers of Chemotherapy Induced Peripheral Neuropathy Treatment
Table: Chemotherapy Induced Peripheral Neuropathy Treatment Main Sales Modes and Sales Channels
Table: Development Opportunities and Key Driving Factors of Chemotherapy Induced Peripheral Neuropathy Treatment Industry
Table: Risks Faced by Chemotherapy Induced Peripheral Neuropathy Treatment Industry Development
Table: Chemotherapy Induced Peripheral Neuropathy Treatment Industry Policy Analysis
Table: Research Scope
Table: List of Analysts
Chart Catalog
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Product Picture
Figure Global Production Market Share of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Consumption Market Share by Application
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Capacity Utilization and Development Trend
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Production, Demand and Development Trend
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Production Market Share by Major Regions
Figure China Chemotherapy Induced Peripheral Neuropathy Treatment Capacity, Production, Capacity Utilization and Development Trend
Figure China Chemotherapy Induced Peripheral Neuropathy Treatment Production, Market Demand and Development Trend
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Sales and Growth Rate.
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size
Figure Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Growth Rate
Figure Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Price Trend
Figure Global Market Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share of Major Manufacturers in 2025
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share of Key Manufacturers in Global Market in 2025
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Share of Key Manufacturers in China Market in 2025
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Market Share of Key Manufacturers in China Market, 2025
Figure 2025 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share of Top 5 Manufacturers
Figure 2025 Global Chemotherapy Induced Peripheral Neuropathy Treatment First Tier, Second Tier and Third Tier Manufacturers (by Brand) and Market Share
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Market Share by Major Regions
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Growth Rate
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Growth Rate
Figure Europe Market Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Growth Rate
Figure Europe Market Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Growth Rate
Figure China Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Growth Rate
Figure China Market Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Growth Rate
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Sales and Growth Rate in Japan Market
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Growth Rate in Japan Market
Figure Global Price Trend of Chemotherapy Induced Peripheral Neuropathy Treatment by Product Type
Figure Global Price Trend of Chemotherapy Induced Peripheral Neuropathy Treatment by Application
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Industry Chain
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Chinese Companies SWOT Analysis
Figure Key Interview Objectives

The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:

Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.

Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.

Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.

Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.

Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.